1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > Vital Signs The Analyst%s Perspective - November 2015 Issue 

Vital Signs The Analyst%s Perspective - November 2015 Issue 

  • January 2016
  • -
  • Frost & Sullivan
  • -
  • 7 pages

This issue of Vital Signs discusses MDxHealth's launch of the SelectMDx Liquid Biopsy Test in Europe, the FDA's approval of a new treatment for non-small cell lung cancer with EGFR mutations, the clamp down on specialty pharmacies by US drug benefit managers, and BGI's strategy redirection for Complete Genomics.

Table Of Contents

Vital Signs The Analyst%s Perspective - November 2015 Issue 
MDxHealth Launches SelectMDx Liquid Biopsy Test in Europe 2
FDA Approves New Treatment for Non-small Cell Lung Cancer with EGFR Mutations 3
US Drug Benefit Managers Clamp Down on Specialty Pharmacies 4
Sequencing Service Provider Stops Planned Instrument Launch, Redirects Strategy 6

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Life Science Instruments & Reagents Global Market - Forecast to 2023

Life Science Instruments & Reagents Global Market - Forecast to 2023

  • $ 5400
  • Industry report
  • February 2017
  • by IQ4I Research & Consultancy Pvt. Ltd

This report studies the life science instruments and reagents market over the forecast period of 2017 to 2023. The life science instruments and reagents market is expected to grow at a high single digit ...

Next Generation Sequencing - Global Market Outlook (2016-2022)

Next Generation Sequencing - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • January 2017
  • by Stratistics MRC

According to Stratistics MRC, the Global Next Generation Sequencing market is estimated at $3.41 billion in 2015 and is expected to reach $13.50 billion by 2022 growing at a CAGR of 21.73% from 2015 to ...

Global Next Generation Sequencing Market Growth, Trends & Forecasts (2017 - 2022)

Global Next Generation Sequencing Market Growth, Trends & Forecasts (2017 - 2022)

  • $ 4250
  • Industry report
  • January 2017
  • by Mordor Intelligence LLP

Next generation sequencing, also known as high-throughput sequencing, is a DNA sequencing technology that has revolutionized genomic research. Due to its ability to sequence DNA, NGS technologies have ...


Download Unlimited Documents from Trusted Public Sources

Genetic Industry in Africa

  • March 2017
    12 pages
  • Genetic  

  • Africa  

    United States  

View report >

Chromosome Industry in the US

  • March 2017
    3 pages
  • Chromosome  

    Genetic Disorde...  

  • United States  

View report >

Genome Sequencing Industry in the US

  • March 2017
    65 pages
  • Genome Sequenci...  

  • United States  

View report >

Genomics Industry

2 months ago

Cytogenetic Statistics

3 months ago

Related Market Segments :

Genome Sequencing
Genomics

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.